Ticagrelor, an oral antiplatelet
indicated for use in acute coronary
syndromes, is a reversibly binding
P2Y12 receptor antagonist and
the subject of this week’s RGH
Pharmacy E-Bulletin.
The Bulletin discusses the
literature around the effects of
ticagrelor-induced dyspnoea.
CLICK HERE to read.
THE Consumers Health Forum of Australia (CHF) is seeking a voice at the table when negotiations begin for the next Community Pharmacy Agreement (CPA) following confirmation by Health Minister Greg Hunt that the Pharmaceutical Society of Australia (PSA) will also be involved (PD yesterday).
CONSIDERED one of Australia’s most urgent public health crises, opioid-related harm is the central theme in the latest issue of the Society of Hospital Pharmacists of Australia (SHPA)’s flagship organ the Journal of Pharmacy Practice and Research (JPPR).
FEDERAL Health Minister Greg Hunt has made a commitment to build into the Seventh Community Pharmacy Agreement (7CPA) “the expanded scope of practice, where pharmacy will be involved increasingly in preventive health.”